Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00406640
What this trial is testing

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Who this might be right for
DepressionDepressive DisorderDepressive Disorder, Major
Wyeth is now a wholly owned subsidiary of Pfizer 595
Testing effectiveness (Phase 2)Study completedNCT00827918
What this trial is testing

Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 216
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Post-approval studies (Phase 4)Study completedNCT00489255
What this trial is testing

Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment

Who this might be right for
Parkinson's Disease
Ipsen 117
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07754825
What this trial is testing

A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd 300
Not applicableStudy completedNCT06097923
What this trial is testing

Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)

Who this might be right for
Fluid OverloadFluid Loss
Seoul St. Mary's Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02509546
What this trial is testing

8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT02917291
What this trial is testing

Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury

Who this might be right for
Acute Traumatic Spinal Cord Injury
Ferrer Internacional S.A. 48
Testing effectiveness (Phase 2)Study completedNCT00607997
What this trial is testing

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Who this might be right for
LeukemiaAcute DiseaseAcute Myeloid Leukemia+2 more
Sunesis Pharmaceuticals 113
Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Not applicableUnknownNCT02735291
What this trial is testing

Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia

Who this might be right for
Leukemia
Sinobioway Cell Therapy Co., Ltd. 72
Early research (Phase 1)Looking for participantsNCT07025564
What this trial is testing

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00853112
What this trial is testing

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Pfizer 48
Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203
Testing effectiveness (Phase 2)Study completedNCT04772781
What this trial is testing

Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain

Who this might be right for
Low Back Pain, MechanicalLow Back PainAcute Low Back Pain
Apsen Farmaceutica S.A. 177
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264
What this trial is testing

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 218
Early research (Phase 1)Ended earlyNCT03761069
What this trial is testing

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcuteAML
PTC Therapeutics 33
Large-scale testing (Phase 3)Study completedNCT00975000
What this trial is testing

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Who this might be right for
Chronic Allograft NephropathyChronic Kidney DiseaseChronic Renal Failure+7 more
Amgen 114
Testing effectiveness (Phase 2)Study completedNCT01016600
What this trial is testing

Azacitidine and Lenalidomide for Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 31
Early research (Phase 1)Study completedNCT02316964
What this trial is testing

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Sumithira Vasu 8
Next Page